1. Executive Summary
2. Global Aquaculture Vaccines Market Introduction
2.1. Global Aquaculture Vaccines Market – Taxonomy
2.2. Global Aquaculture Vaccines Market –Definitions
2.2.1. Type of Vaccine
2.2.2. Application
2.2.3. Species
2.2.4. Route of Administration
3. Global Aquaculture Vaccines Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Aquaculture Vaccines Market Dynamics – Factors Impact Analysis
3.6. Global Aquaculture Vaccines Market – Regulations
3.6.1. U.S
3.6.2. Europe
3.6.3. Japan
3.6.4. China
3.7. Global Aquaculture Vaccines Market – Product Innovations
4. Global Aquaculture Vaccines Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis
5. Global Aquaculture Vaccines Market, By Product, 2013 – 2017 and Forecast, 2018 – 2024
5.1. Inactivated vaccines
5.1.1. Inactivated virus or bacterial antigens
5.1.2. Sub-unit vaccines
5.1.3. Recombinant vaccines
5.2. Live vaccines
5.2.1. Attenuated live vaccines
5.2.2. Gene-deleted live vaccines
5.3. DNA vaccine
5.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.3.3. Market Opportunity Analysis
6. Global Aquaculture Vaccines Market Forecast, By Application, 2013 – 2017 and Forecast, 2018 – 2024
6.1. Bacterial infections
6.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.1.3. Market Opportunity Analysis
6.2. Viral infections
6.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.2.3. Market Opportunity Analysis
6.3. Fungal infections
6.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.3.3. Market Opportunity Analysis
6.4. Parasitic infections
6.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
6.4.3. Market Opportunity Analysis
7. Global Aquaculture Vaccines Market Forecast, By Species, 2013 – 2017 and Forecast, 2018 – 2024
7.1. Carps
7.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.1.3. Market Opportunity Analysis
7.2. Carp
7.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.2.3. Market Opportunity Analysis
7.3. Salmon
7.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.3.3. Market Opportunity Analysis
7.4. Sea Bass
7.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.4.3. Market Opportunity Analysis
7.5. Sturgeon
7.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.5.3. Market Opportunity Analysis
7.6. Trout
7.6.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.6.3. Market Opportunity Analysis
7.7. Turbot
7.7.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.7.3. Market Opportunity Analysis
7.8. Sea bream
7.8.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.8.3. Market Opportunity Analysis
7.9. Others
7.9.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
7.9.3. Market Opportunity Analysis
8. Global Aquaculture Vaccines Market Forecast, By Route of Administration, 2013 – 2017 and Forecast, 2018 – 2024
8.1. Immersion vaccination
8.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
8.1.3. Market Opportunity Analysis
8.2. Injection vaccination
8.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
8.2.3. Market Opportunity Analysis
8.3. Oral vaccination
8.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
8.3.3. Market Opportunity Analysis
8.4. Spray vaccination
8.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
8.4.3. Market Opportunity Analysis
9. Global Aquaculture Vaccines Market Forecast, By Region, 2013 – 2017 and Forecast, 2018 – 2024
9.1. North America
9.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
9.5.3. Market Opportunity Analysis
9.6. Global Aquaculture Vaccines Market – Opportunity Analysis Index, By Vaccine Type, Application, Species, Route of Administration and Region, 2018 – 2024
10. North America Aquaculture Vaccines Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
10.1. Vaccine Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Inactivated vaccines
10.1.1.1. Inactivated virus or bacterial antigens
10.1.1.2. Sub-unit vaccines
10.1.1.3. Recombinant vaccines
10.1.2. Live vaccines
10.1.2.1. Attenuated live vaccines
10.1.2.2. Gene-deleted live vaccines
10.1.2.3. DNA vaccines
10.1.3. Others
10.2. Application Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Bacterial infections
10.2.2. Viral infections
10.2.3. Fungal infections
10.2.4. Parasitic infections
10.3. Species Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Carp
10.3.2. Salmon
10.3.3. Seabass
10.3.4. Sturgeon
10.3.5. Trout
10.3.6. Turbot
10.3.7. Sea bream
10.3.8. Others
10.4. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. U.S.
10.4.2. Canada
10.5. North America Aquaculture Vaccines Market – Opportunity Analysis Index, By vaccine Type, Application, Species, Route of Administration and Country, 2018 – 2024
10.6. North America Aquaculture Vaccines Market Dynamics – Trends
11. Europe Aquaculture Vaccines Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
11.1. Vaccine Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Inactivated vaccines
11.1.1.1. Inactivated virus or bacterial antigens
11.1.1.2. Sub-unit vaccines
11.1.1.3. Recombinant vaccines
11.1.2. Live vaccines
11.1.2.1. Attenuated live vaccines
11.1.2.2. Gene-deleted live vaccines
11.1.2.3. DNA vaccines
11.1.3. Others
11.2. Application Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Bacterial infections
11.2.2. Viral infections
11.2.3. Fungal infections
11.2.4. Parasitic infections
11.3. Species Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Carp
11.3.2. Salmon
11.3.3. Seabass
11.3.4. Sturgeon
11.3.5. Trout
11.3.6. Turbot
11.3.7. Sea bream
11.3.8. Others
11.4. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Germany
11.4.2. UK
11.4.3. France
11.4.4. Spain
11.4.5. Italy
11.4.6. Russia
11.4.7. Poland
11.4.8. Rest of Europe
11.5. Europe Aquaculture Vaccines Market – Opportunity Analysis Index, , By Vaccine Type, Application, Species, Route of Administration and Country, 2018 – 2024
11.6. Europe Aquaculture Vaccines Market Dynamics – Trends
12. Asia-Pacific Aquaculture Vaccines Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
12.1. Vaccine Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Inactivated vaccines
12.1.1.1. Inactivated virus or bacterial antigens
12.1.1.2. Sub-unit vaccines
12.1.1.3. Recombinant vaccines
12.1.2. Live vaccines
12.1.2.1. Attenuated live vaccines
12.1.2.2. Gene-deleted live vaccines
12.1.2.3. DNA vaccines
12.1.3. Others
12.2. Application Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Bacterial infections
12.2.2. Viral infections
12.2.3. Fungal infections
12.2.4. Parasitic infections
12.3. Species Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Carp
12.3.2. Salmon
12.3.3. Seabass
12.3.4. Sturgeon
12.3.5. Trout
12.3.6. Turbot
12.3.7. Sea bream
12.3.8. Others
12.4. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.4.1. Japan
12.4.2. China
12.4.3. India
12.4.4. ASEAN
12.4.5. Australia & New Zealand
12.4.6. Rest of Asia-Pacific
12.5. Asia-Pacific Aquaculture Vaccines Market – Opportunity Analysis Index, , By Vaccine Type, Application, Species, Route of Administration and Country, 2018 – 2024
12.6. Europe Aquaculture Vaccines Market Dynamics – Trends
13. Latin America Aquaculture Vaccines Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
13.1. Vaccine Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Inactivated vaccines
13.1.1.1. Inactivated virus or bacterial antigens
13.1.1.2. Sub-unit vaccines
13.1.1.3. Recombinant vaccines
13.1.2. Live vaccines
13.1.2.1. Attenuated live vaccines
13.1.2.2. Gene-deleted live vaccines
13.1.2.3. DNA vaccines
13.1.3. Others
13.2. Application Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Bacterial infections
13.2.2. Viral infections
13.2.3. Fungal infections
13.2.4. Parasitic infections
13.3. Species Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Carp
13.3.2. Salmon
13.3.3. Seabass
13.3.4. Sturgeon
13.3.5. Trout
13.3.6. Turbot
13.3.7. Sea bream
13.3.8. Others
13.4. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Brazil
13.4.2. Mexico
13.4.3. Argentina
13.4.4. Venezuela
13.4.5. Rest of Latin America
13.5. Latin America Aquaculture Vaccines Market – Opportunity Analysis Index, By Vaccine Type, Application, Species, Route of Administration and Country, 2018 – 2024
13.6. Latin America Aquaculture Vaccines Market Dynamics – Trends
14. Middle East and Africa Aquaculture Vaccines Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
14.1. Vaccine Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Inactivated vaccines
14.1.1.1. Inactivated virus or bacterial antigens
14.1.1.2. Sub-unit vaccines
14.1.1.3. Recombinant vaccines
14.1.2. Live vaccines
14.1.2.1. Attenuated live vaccines
14.1.2.2. Gene-deleted live vaccines
14.1.2.3. DNA vaccines
14.1.3. Others
14.2. Application Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.2.1. Bacterial infections
14.2.2. Viral infections
14.2.3. Fungal infections
14.2.4. Parasitic infections
14.3. Species Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Carp
14.3.2. Salmon
14.3.3. Seabass
14.3.4. Sturgeon
14.3.5. Trout
14.3.6. Turbot
14.3.7. Sea bream
14.3.8. Others
14.4. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.4.1. Gulf Cooperation Council (GCC) Countries
14.4.2. Israel
14.4.3. South Africa
14.4.4. Rest of MEA
14.5. MEA Aquaculture Vaccines Market – Opportunity Analysis Index, , By Vaccine Type, Application, Species, Route of Administration and Country, 2018 – 2024
14.6. MEA Aquaculture Vaccines Market Dynamics – Trends
15. Competition Landscape
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Zoetis (Pfizer Inc.) (U.S.)
15.2.2. Benchmark Holdings Plc. (U.K.)
15.2.3. Ridgeway Biologicals Ltd. (U.K.)
15.2.4. Virbac (France)
15.2.5. Vaccibody AS (Bio-Medisinsk Innovasjon AS) (Norway)
15.2.6. Merck & Co. Inc. (U.S.)
15.2.7. Bayer Animal Health (Germany)
16. Research Methodology
17. Key Assumptions and Acronyms